Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry: General results and subanalyses
Authors:
- Kazunori ToyodaKTKazunori Toyoda
- Masatoshi KogaMKMasatoshi Koga
- Yoshiaki ShiokawaYSYoshiaki Shiokawa
- Jyoji NakagawaraJNJyoji Nakagawara
- Eisuke FuruiEFEisuke Furui
- Kazumi KimuraKKKazumi Kimura
- Hiroshi YamagamiHYHiroshi Yamagami
- Yasushi OkadaYOYasushi Okada
- Yasuhiro HasegawaYHYasuhiro Hasegawa
- Kazuomi KarioKKKazuomi Kario
- Satoshi OkudaSOSatoshi Okuda
- Masaki NaganumaMNMasaki Naganuma
- 1 January 2010
- journal article
- Published by Japan Stroke Society in Japanese Journal of Stroke
- Vol. 32 (6) , 756-761
Abstract
国内10施設が参加した厚生労働科学研究Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registryに登録された急性期脳梗塞患者600例(女性 223例,72±12歳)の,遺伝子組み換え組織型プラスミノゲン・アクティベータ(recombinant tissue-type plasminogen activator: rt-PA)静注療法の治療成績を,紹介する.治療後36時間以内に119例(19.8%,16.8–23.2%)に頭蓋内出血を,8例(1.3%,0.7–2.6%)に症候性頭蓋内出血(SITS-MOST定義)を認めた.3カ月後に199例(33.2%,95% CI 29.5–37.0%)が完全自立(modified Rankin Scale [mRS] 0–1)した.欧州のrt-PA適応基準にしたがって患者を限定すると,399例中162例(40.6%,35.9–45.5%)が完全自立し,この割合は他の国内外の市販後調査成績と同等であった.サブ解析で,MRI拡散強調画像での早期虚血所見や腎機能障害の存在が,治療成績と良く相関することを明らかにした.Keywords
This publication has 9 references indexed in Scilit:
- Reduced Estimated Glomerular Filtration Rate Is Associated with Stroke Outcome after Intravenous rt-PA: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA RegistryCerebrovascular Diseases, 2010
- Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical PracticeStroke, 2010
- Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PANeurology, 2010
- Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese PatientsStroke, 2009
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of OnsetStroke, 2006
- Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapyThe Lancet, 2000
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995